Phosphorex provides drug delivery solutions to the pharmaceutical and biopharmaceutical industries, which include drug encapsulation, nanosizing, microemulsion, and surface functionalization and coating. Following is a brief summary of our expertise:
• Microencapsulation/nanoencapsulation of small molecule active pharmaceutical ingredients (APIs) or biomolecules into biodegradable microspheres or nanoparticles enables controlled or sustained drug release, protecting APIs from premature degradation as well as increasing circulation time and targeted drug delivery.
• Nanosizing can help you transform poorly soluble APIs with low bioavailability into nanocrystals that can be delivered more easily with enhanced solubility and bioavailability.
• Microemulsion, in which a poorly soluble API is dissolved in oil and micro-emulsified into an aqueous media to form a homogeneous mix.
• Surface functionalization and coating in which we attach a biological entity on the surface of drug loaded microspheres or nanoparticles via either covalent bonding or physical adsorption to enable cell entry, brain-blood barrier crossing, and targeted drug delivery.
The services we provide apply to all stages of your drug development efforts. Whether you are testing a new idea, conducting animal studies, or moving to clinical studies, we can assist. With our fully integrated cGMP system, we can assure you that our processes are completely reproducible and scalable.
Please visit www.phosphorex.com for more information.
-
Industry
-
Biotechnology Research
-
Company size
-
11-50 employees
-
Headquarters
-
Hopkinton, MA
-
Type
-
Privately Held
-
Founded
-
2005
-
Specialties
-
drug delivery, nanoparticles, microspheres, polymeric nanoparticles, controlled release, targeted drug delivery, solubility enhancement, LNPs, PNPs, Lipids Nano Particles, Long acting injectables, particle-based formulation, CDMO, formulation of nRNAs & DNAs, vaccine development, gene delivery, oligonucleotide, pharma, biotech, drug release, and mRNAs
